FMR »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by FMR

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by FMR from 13F filings

Historical chart of FMR investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by FMR

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.4M 7.2M 1.03

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation Put Option (XOM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Netflix (NFLX)
Ge Vernova Put Option (GEV)
Ge Aerospace Com New (GE)
Visa Com Cl A (V)

View all positions for FMR

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1